"Drug Interactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The action of a drug that may affect the activity, metabolism, or toxicity of another drug.
| Descriptor ID |
D004347
|
| MeSH Number(s) |
G07.690.773.968
|
| Concept/Terms |
Drug Interactions- Drug Interactions
- Drug Interaction
- Interaction, Drug
- Interactions, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Interactions".
Below are MeSH descriptors whose meaning is more specific than "Drug Interactions".
This graph shows the total number of publications written about "Drug Interactions" by people in this website by year, and whether "Drug Interactions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 4 | 4 |
| 1997 | 0 | 3 | 3 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 5 | 5 |
| 2000 | 1 | 9 | 10 |
| 2001 | 2 | 4 | 6 |
| 2002 | 0 | 12 | 12 |
| 2003 | 0 | 9 | 9 |
| 2004 | 0 | 8 | 8 |
| 2005 | 0 | 15 | 15 |
| 2006 | 0 | 4 | 4 |
| 2007 | 2 | 6 | 8 |
| 2008 | 0 | 4 | 4 |
| 2009 | 0 | 8 | 8 |
| 2010 | 2 | 8 | 10 |
| 2011 | 0 | 3 | 3 |
| 2012 | 1 | 4 | 5 |
| 2013 | 1 | 4 | 5 |
| 2014 | 1 | 3 | 4 |
| 2015 | 1 | 7 | 8 |
| 2016 | 3 | 1 | 4 |
| 2017 | 1 | 6 | 7 |
| 2018 | 3 | 7 | 10 |
| 2019 | 1 | 3 | 4 |
| 2020 | 1 | 3 | 4 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 2 | 2 |
| 2024 | 1 | 1 | 2 |
| 2025 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Interactions" by people in Profiles.
-
HIV-associated drug-resistant TB: expanded treatment options and emerging threats. Curr Opin HIV AIDS. 2026 Mar 01; 21(2):172-179.
-
Pharmacokinetic Interactions Between Ethanol and PT150, a Selective Glucocorticoid Receptor Antagonist, in Healthy Volunteers. J Addict Med. 2026 Jul-Aug 01; 20(4):409-415.
-
Comparing the clinical utility of pharmacogenomic genotyping and next generation sequencing in a military health system adult medicine clinic. Pharmacogenomics. 2024; 25(16-18):637-645.
-
Clinical implications of combination proton pump inhibitor and triple therapies in patients with atrial fibrillation following percutaneous intervention: a guide for clinicians. Expert Rev Cardiovasc Ther. 2024 Sep; 22(9):483-491.
-
A Calculated Risk: Evaluation of QTc Drug-Drug Interaction (DDI) Clinical Decision Support (CDS) Alerts and Performance of the Tisdale Risk Score Calculator. Drug Saf. 2024 Dec; 47(12):1235-1243.
-
Investigating Potential Drug-Drug Interactions in Pediatric and Adolescent Patients Receiving Chemotherapy. J Oncol Pharm Pract. 2022 Jun; 28(4):904-909.
-
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions. Nat Commun. 2021 03 12; 12(1):1660.
-
Impact of Protease Inhibitor-Based Antiretroviral Therapy on Tacrolimus Intrapatient Variability in HIV-Positive Kidney Transplant Recipients. Transplant Proc. 2021 Apr; 53(3):984-988.
-
It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV. Am J Trop Med Hyg. 2020 10; 103(4):1348-1349.
-
Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans. Mol Imaging Biol. 2020 06; 22(3):722-729.